LRRK2 Pro755Leu variant in ethnic Chinese population with Parkinson's disease

Neuroscience Letters

Volumn 495, Issue 1, 2011, Pages 35-38

  Yao, Ling yan ^a   Guo, Ji feng ^a   Wang, Lei ^a   Yu, Ren he ^b   Sun, Qi ying ^a   Pan, Qian ^b   Xia, Kun ^b   Tang, Bei sha ^b   Shen, Lu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asia; Chinese; LRRK2; Parkinson's disease; Polymorphism; Pro755Leu

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 79955022794     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.030     Document Type: Article

References (39)

1. An X.K., Peng R., Li T., Burgunder J.M., Wu Y., Chen W.J., Zhang J.H., Wang Y.C., Xu Y.M., Gou Y.R., Yuan G.G., Zhang Z.J. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Eur. J. Neurol. 2008, 15:301-305.
2. Bras J.M., Guerreiro R.J., Ribeiro M.H., Januario C., Morgadinho A., Oliveira C.R., Cunha L., Hardy J., Singleton A. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov. Disord. 2005, 20:1653-1655.
3. Cao L., Zhang T., Xiao Q., Wang Y., Bai L., Lu G.Q., Ma J.F., Zhang J., Ding J.Q., Chen S.D. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease. Mov. Disord. 2007, 22:2439-2443.
4. Carmine Belin A., Westerlund M., Sydow O., Lundströmer K., Håkansson A., Nissbrandt H., Olson L., Galter D. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy Nonagenarian. Mov. Disord. 2006, 21:1731-1734.
5. Deng H., Le W., Huang M., Xie W., Pan T., Jankovic J. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease. Neurosci. Lett. 2007, 419:104-107.
6. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415.
7. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohé C.F., Chang H.C., Chen R.S., Weng Y.H., Vanacore N., Breedveld G.J., Oostra B.A., Bonifati V. A common missense variant in the LRRK2 gene, Gly2385Arg, association with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7:133-138.
8. Farrer M.J., Stone J.T., Lin C.H., Dächsel J.C., Hulihan M.M., Haugarvoll K., Ross O.A., Wu R.M. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat. Disord. 2007, 13:89-92.
9. Funayama M., Li Y., Tomiyama H., Yoshino H., Imamichi Y., Yamamoto M., Murata M., Toda T., Mizuno Y., Hattori N. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 2007, 18:273-275.
10. Fung H.C., Chen C.M., Hardy J., Hernandez D., Singleton A., Wu Y.R. Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease. Mov. Disord. 2006, 21:880-881.
11. Fung H.C., Chen C.M., Hardy J., Singleton A.B., Wu Y.R. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol. 2006, 6:47.
12. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365:415-416.
13. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
14. Kim J.M., Lee J.Y., Kim H.J., Kim J.S., Shin E.S., Cho J.H., Park S.S., Jeon B.S. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Parkinsonism Relat. Disord. 2010, 16:85-88.
15. Lesage S., Dürr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., Pollak P., Brice A. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 2006, 354:422-423.
16. Lu C.S., Simons E.J., Wu-Chou Y.H., Fonzo A.D., Chang H.C., Chen R.S., Weng Y.H., Rohé C.F., Breedveld G.J., Hattori N., Gasser T., Oostra B.A., Bonifati V. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat. Disord. 2005, 11:521-522.
17. Lu C.S., Wu-Chou Y.H., van Doeselaar M., Simons E.J., Chang H.C., Breedveld G.J., Di Fonzo A., Chen R.S., Weng Y.H., Lai S.C., Oostra B.A., Bonifati V. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 2008, 9:271-276.
18. Mata I.F., Kachergus J.M., Taylor J.P., Lincoln S., Aasly J., Lynch T., Hulihan M.M., Cobb S.A., Wu R.M., Lu C.S., Lahoz C., Wszolek Z.K., Farrer M.J. lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005, 6:171-177.
19. Mata I.F., Wedemeyer W.J., Farrer M.J., Taylor J.P., Gallo K.A. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 2006, 29:286-293.
20. Nichols W.C., Pankratz N., Hernandez D., Paisán-Ruíz C., Jain S., Halter C.A., Michaels V.E., Reed T., Rudolph A., Shults C.W., Singleton A., Foroud T. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet. 2005, 365:410-412.
21. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2006, 354:424-425.
22. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
23. Pankratz N., Pauciulo M.W., Elsaesser V.E., Marek D.K., Halter C.A., Rudolph A., Shults C.W., Foroud T., Nichols W.C. Mutations in LRRK2 other than G2019S are rare in a North American-based sample of familial Parkinson's disease. Mov. Disord. 2006, 21:2257-2260.
24. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., Mata I.F., Lee-Chen G.J., Chen C.M., Tang M., Zhao Y., Hattori N., Farrer M.J., Tan E.K., Wu R.M. Analysis of lrrk2 R1628P as a risk factor for Parkinson's disease. Ann. Neurol. 2008, 64:88-92.
25. Skipper L., Li Y., Bonnard C., Pavanni R., Yih Y., Chua E., Sung W.K., Tan L., Wong M.C., Tan E.K., Liu J. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum. Mol. Genet. 2005, 14:3549-3556.
26. Tan E.K., Lim H.Q., Yuen Y., Zhao Y. Pathogenicity of LRRK2 P755L variant in Parkinson's disease. Mov. Disord. 2008, 23:734-736.
27. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., Jamora R.D., Puvan K., Puong K.Y., Zhao Y., Pavanni R., Wong M.C., Yih Y., Skipper L., Liu J.J. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci. Lett. 2005, 384:327-329.
28. Tan E.K., Skipper L., Tan L., Liu J.J. LRRK2 G2019S founder haplotype in the Chinese population. Mov. Disord. 2007, 22:105-107.
29. Tan E.K., Tan L.C., Lim H.Q., Li R., Tang M., Yih Y., Pavanni R., Prakash K.M., Fook-Chong S., Zhao Y. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum. Genet. 2008, 124:287-288.
30. Tan E.K., Tang M., Tan L.C., Wu Y.R., Wu R.M., Ross O.A., Zhao Y. Lrrk2 R1628P in non-Chinese Asian races. Ann. Neurol. 2008, 64:472-473.
31. Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., Fook-Chong S., Tang S., Chua E., Yuen Y., Tan L., Pavanni R., Wong M.C., Kolatkar P., Lu C.S., Bonifati V., Liu J.J. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum. Genet. 2007, 120:857-863.
32. Tan E.K., Zhao Y., Tan L., Lim H.Q., Lee J., Yuen Y., Pavanni R., Wong M.C., Fook-Chong S., Liu J.J. Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians. Mov. Disord. 2007, 22:1816-1818.
33. Toft M., Haugarvoll K., Ross O.A., Farrer M.J., Aasly J.O. LRRK2 and Parkinson's disease in Norway. Acta Neurol. Scand. Suppl. 2007, 187:72-75.
34. Tomiyama H., Mizuta I., Li Y., Funayama M., Yoshino H., Li L., Murata M., Yamamoto M., Kubo S., Mizuno Y., Toda T., Hattori N. LRRK2 P755L variant in sporadic Parkinson's disease. Hum. Genet. 2008, 53:1012-1015.
35. Wu T., Zeng Y., Ding X., Li X., Li W., Dong H., Chen S., Zhang X., Ma G., Yao J., Deng X. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease. Neuroreport 2006, 17:1859-1862.
36. Yu L., Hu F., Zou X., Jiang Y., Liu Y., He X., Xi J., Liu L., Liu Z., He L., Xu Y. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China. Brain. Res. 2009, 1296:113-116.
37. Zabetian C.P., Yamamoto M., Lopez A.N., Ujike H., Mata I.F., Izumi Y., Kaji R., Maruyama H., Morino H., Oda M., Hutter C.M., Edwards K.L., Schellenberg G.D., Tsuang D.W., Yearout D., Larson E.B., Kawakami H. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov. Disord. 2009, 24:1034-1041.
38. Zhang Z., Burgunder J.M., An X., Wu Y., Chen W., Zhang J., Wang Y., Xu Y., Gou Y., Yuan G., Mao X., Peng R. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Mov. Disord. 2009, 24:1902-1905.
39. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.